[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-343021-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-343021-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","nop2-facilitates-ezh2-mediated-epithelialmesenchymal-transition-by-enhancing-ezh2-mrna-stability-via-m5c-methylation-in-lung-cancer-progression-article-summary","NOP2 facilitates EZH2-mediated epithelial–mesenchymal transition by enhancing EZH2 mRNA stability via m5C methylation in lung cancer progression - Article summary","","NOP2 is investigated for its role in lung adenocarcinoma progression through RNA 5-methylcytosine (m5C) regulation. NOP2 is significantly upregulated in LUAD tissues and cells, and its overexpression increases migration, invasion, tumor growth, and metastasis, whereas NOP2 knockdown suppresses these phenotypes. Mechanistically, NOP2 enhances m5C-dependent stability of EZH2 mRNA via a co-regulatory relationship with ALYREF, activating an NOP2/EZH2 axis that promotes EMT in vitro and in vivo.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/nop2-facilitates-ezh2-mediated-epithelialmesenchymal-transition-by-enhancing-ezh2-mrna-stability-via-m5c-methylation-in-lung-cancer-progression-article-summary/343021/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/nop2-facilitates-ezh2-mediated-epithelialmesenchymal-transition-by-enhancing-ezh2-mrna-stability-via-m5c-methylation-in-lung-cancer-progression-article-summary/343021.png","ImageObject",300,407,{"name":42,"@type":43},"Liam","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-25","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does NOP2 affect lung cancer cell behavior in the study?","Question",{"text":63,"@type":64},"NOP2 overexpression enhances lung cancer cell migration and invasion in vitro, and promotes xenograft tumor growth and metastasis in vivo. In contrast, NOP2 knockdown inhibits growth and metastasis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is the mechanistic link between NOP2 and EZH2?",{"text":68,"@type":64},"NOP2 increases EZH2 mRNA expression and, through an m5C-dependent mechanism, enhances EZH2 mRNA stability. The study also identifies a co-regulatory relationship between NOP2 and the m5C reader ALYREF.",{"name":70,"@type":61,"acceptedAnswer":71},"How does EZH2 contribute to EMT in LUAD according to the document?",{"text":72,"@type":64},"The NOP2/EZH2 axis facilitates the malignant phenotype by inducing epithelial–mesenchymal transition (EMT) in both in vitro and in vivo settings. ChIP analysis shows EZH2 counteracts NOP2 effects on EZH2 and H3K27me3 occupancy at the E-cadherin promoter.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},343021,1790203729,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":33,"preview_urls":145},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nNOP2 facilitates EZH2-mediated epithelial–mesenchymal transition by enhancing EZH2 mRNA stability via m5Cmethylation in lung cancer progression  \nYing Yang1,6, Hongzhao Fan2,6, Hongyang Liu3,6, Xueling Lou3, Nan Xiao1, Chenxing Zhang 1, Huanxiang Chen4, Shuangshuang Chen5, Huihui Gu4 ✉, Hongchun Liu 1 ✉ and Junhu Wan 1 ✉  \n© The Author(s) 2024  \n|  |  |  |\n| --- | --- | --- |\n|  | NOP2, a member of the NOL1/NOP2/SUN domain (NSUN) family, is responsible for catalyzing the posttranscriptional modiﬁcation of RNA through 5-methylcytosine (m5C) . Dysregulation of m5C modiﬁcation has been linked to the pathogenesis of various malignant tumors. Herein, we investigated the expression of NOP2 in lung adenocarcinoma (LUAD) tissues and cells, and found that it was signiﬁcantly upregulated. Moreover, lentivirus-mediated overexpression of NOP2 in vitro resulted in enhanced migration and invasion capabilities of lung cancer cells, while in vivo experiments demonstrated its ability to promote the growth and metastasis of xenograft tumors. In contrast, knockdown of NOP2 effectively inhibited the growth and metastasis of lung cancer cells. RNAsequencing was conducted to ascertain the downstream targets of NOP2, and the ﬁndings revealed a signiﬁcant upregulation in EZH2 mRNA expression upon overexpression of NOP2 . Subsequent validation experiments demonstrated that NOP2 exerted an m5C-dependent inﬂuence on the stability of EZH2 mRNA. Additionally, our investigations revealed a co-regulatory relationship between NOP2 and the m5C reader protein ALYREF in modulating the stability of EZH2 mRNA. Notably, the NOP2/EZH2 axis facilitated the malignant phenotype of lung cancer cells by inducing epithelial–mesenchymal transition (EMT) both in vitro and in vivo. Mechanistically, ChIP analysis proved that EZH2 counteracted the impact of NOP2 on the occupancy capacity of EZH2 and H3K27me3 in the promoter regions of E-cadherin, a gene crucial for regulating EMT. In a word, our research highlights the signiﬁcant role of NOP2 in LUAD and offers novel mechanistic insights into the NOP2/ALYREF/EZH2 axis, which holds promise as a |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| potential target for lung cancer therapy. |  |  |\n|  | Cell Death and Disease (2024)15:506; [https://doi.org/10.1038/s41419-024-06899-w](https://doi.org/10.1038/s41419-024-06899-w) |  |\n|  |  |  |\n\nINTRODUCTION  \nLung cancer, a malignant neoplasm originating in the bronchial mucosa or glands of the lungs, exhibits a high and increasing incidence globally. The pathohistological classiﬁcation of lung cancer primarily encompasses two major categories, namely nonsmall cell lung cancer (NSCLC) and small cell lung cancer (SCLC), and treatment decisions are contingent upon the speciﬁc subtype and stage of the cancer [1] . NSCLC, which accounts for 85% of all lung cancers, is further subdivided into squamous-cell carcinoma, adenocarcinoma, and large-cell carcinoma [2] . Among these, lung adenocarcinoma (LUAD) is the prevailing form of lung cancer, accounting for approximately 40% of all lung cancer cases [3] . Surgical intervention is the primary approach for managing earlystage lung cancer, whereas advanced and metastatic cases necessitate systemic therapy [4, 5] . These treatments can signiﬁcantly improve patients’ symptoms and extend their overall survival. However, the therapeutic efﬁcacy in lung cancer patients is frequently constrained by drug resistance and the evasion of  \napoptosis by tumor cells, culminating in tumor recurrence and unfavorable prognoses [6] . Therefore, it is imperative to investigate the molecular mechanisms and potential therapeutic targets associated with lung cancer.  \nThe m5C methylation occurs at the ﬁfth position of cytosine residues in DNA and RNA, which is catalyzed by m5C methyltransferas","cbCailq5TfEYyUOR","https://ap.wps.com/l/cbCailq5TfEYyUOR","pdf",9758769,16,"English","# Introduction\n## m5C methylation and its regulators\n## Lung cancer background and therapeutic challenges\n# Main findings (study results)\n## NOP2 expression and functional effects\n## NOP2 controls EZH2 via m5C-dependent mRNA stability\n## NOP2/ALYREF/EZH2 axis and EMT","[{\"question\":\"How does NOP2 affect lung cancer cell behavior in the study?\",\"answer\":\"NOP2 overexpression enhances lung cancer cell migration and invasion in vitro, and promotes xenograft tumor growth and metastasis in vivo. In contrast, NOP2 knockdown inhibits growth and metastasis.\"},{\"question\":\"What is the mechanistic link between NOP2 and EZH2?\",\"answer\":\"NOP2 increases EZH2 mRNA expression and, through an m5C-dependent mechanism, enhances EZH2 mRNA stability. The study also identifies a co-regulatory relationship between NOP2 and the m5C reader ALYREF.\"},{\"question\":\"How does EZH2 contribute to EMT in LUAD according to the document?\",\"answer\":\"The NOP2/EZH2 axis facilitates the malignant phenotype by inducing epithelial–mesenchymal transition (EMT) in both in vitro and in vivo settings. ChIP analysis shows EZH2 counteracts NOP2 effects on EZH2 and H3K27me3 occupancy at the E-cadherin promoter.\"}]","NOP2 facilitates EZH2-mediated epithelial–mesenchymal transition by enhancing EZH2 mRNA stability via m5C methylation in lung cancer progression - Article summary | PDF",1790049462,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/61e43f9c87b8e51aea341adb068c4e59.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c2037ba6d5a7bb5c8ce191d86689bd17.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c2b3b669263b0eb3c81d6b58e5ca6093.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a5ca5731330d3b619cd559ec5717f68b.webp",980,1301]